Bayforest Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bayforest Capital’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$69.5K	Sell
2025 Q1	$216K	Sell
2024 Q4	$320K	Buy